| 000 | 01460nam a2200265 4500 | ||
|---|---|---|---|
| 001 | 384311 | ||
| 010 | _a9291681377 | ||
| 090 | _a384311 | ||
| 100 | _a20070529d2003 y0pory50 ba | ||
| 101 | _aeng | ||
| 200 |
_aReport on the risk assessment of PMMA in the framework of the joint action on new synthetic drugs _fEuropean Monitoring Centre for Drugs and Drug Addiction, EMCDDA |
||
| 210 |
_aLuxembourg _cOffice for Official Publications of the European Communities _d2003 |
||
| 215 |
_a122 p. _d21 cm |
||
| 225 |
_aEMCDDA Risk Assessments _v5 |
||
| 330 | _aForeword. Abbreviations. Introduction. Chapter 1: Report on the risk assessment of PMMA in the framework of the joint action on new synthetic drugs. Chapter 2: Council decision. Chapter 3: Europol-EMCDDA progress report on PMMA and PMA. Chapter 4: Review of the pharmacotoxicological data on PMMA. Chapter 5: Sociological and criminological evidence on the risks of PMMA. Chapter 6: Public health risks of PMMA - epidemiological evidence. References. Participants in the risk assessment process. Further reading. | ||
| 606 |
_aPREVENÇÃO DA TOXICODEPENDÊNCIA _9103892 |
||
| 606 |
_aRELATÓRIO _9410454 |
||
| 606 |
_aDROGA SINTÉTICA _9320915 |
||
| 606 |
_aOEDT _9321506 |
||
| 710 |
_aEUROPEAN MONITORING CENTRE FOR DRUGS AND DRUG ADDICTION _9351987 |
||
| 955 | _xOferta | ||